| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Functional Genomics Unit, Gene Targeting Facility, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892;
Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892;
Veterinary and Tumor Pathology Section, Office of Laboratory Animal Science, National Cancer Institute, National Institutes of Health, Frederick, MD 21702;
§
Laboratory of Cell Regulation and Carcinogenesis,
¶
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; and
||
Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
TGF-ß1 null (TGF-ß1-/-) mice die at 3–4 wk of age and show an autoimmune inflammatory phenotype associated with enhanced expression of both class I and II MHC molecules. To determine the role of MHC class I Ags in the autoimmune manifestations and the inflammation observed in TGF-ß1-/- mice, we generated TGF-ß1-/- mice in the genetic background of ß2-microglobulin deficiency (ß2M-/-). TGF-ß1-/-;ß2M-/- mice had improved survival compared with TGF-ß1-/- mice. Histopathological examination showed less severe inflammation, especially in the heart, where Mac-2 reactive macrophages were significantly decreased as compared with TGF-ß1-/- mice. In vivo depletion of CD8+ T cells in TGF-ß1-/- mice confirmed suppression of inflammation and reduction in the severity of the wasting syndrome. MHC class II mRNA expression in TGF-ß1-/-;ß2M-/- mice was also lower than that in TGF-ß1-/- mice, suggesting reduced systemic inflammation. Autoimmune response as judged by serum Ab titers to ssDNA and 16/6 Id and by immune complex deposits in kidney was reduced in TGF-ß1-/-;ß2M-/- mice, when compared with that in TGF-ß1-/- mice. Our data thus indicate that MHC class I molecules influence the development of the autoimmunity and the inflammation seen in TGF-ß1-/- mice and CD8+ T cells may have a contribution to the inflammation in TGF-ß1-/- mice.
This article has been cited by other articles:
|
|
 |
|
  M. J. Gros, P. Naquet, and R. R. Guinamard Cell Intrinsic TGF-{beta}1 Regulation of B Cells J. Immunol., June 15, 2008; 180(12): 8153 - 8158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. V. Ingman and R. L. Jones Cytokine knockouts in reproduction: the use of gene ablation to dissect roles of cytokines in reproductive biology Hum. Reprod. Update, March 1, 2008; 14(2): 179 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. V. Ingman and S. A. Robertson Transforming Growth Factor-{beta}1 Null Mutation Causes Infertility in Male Mice Associated with Testosterone Deficiency and Sexual Dysfunction Endocrinology, August 1, 2007; 148(8): 4032 - 4043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Shimizu, S. Kondo, M. Urushihara, M. Takamatsu, K. Kanemoto, M. Nagata, and S. Kagami Role of integrin-linked kinase in epithelial-mesenchymal transition in crescent formation of experimental glomerulonephritis Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2380 - 2390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. V. Ingman, R. L. Robker, K. Woittiez, and S. A. Robertson Null Mutation in Transforming Growth Factor {beta}1 Disrupts Ovarian Function and Causes Oocyte Incompetence and Early Embryo Arrest Endocrinology, February 1, 2006; 147(2): 835 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Z. Mehal, S. Z. Sheikh, L. Gorelik, and R. A. Flavell TGF-{beta} signaling regulates CD8+ T cell responses to high- and low-affinity TCR interactions Int. Immunol., May 1, 2005; 17(5): 531 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. McKarns and R. H. Schwartz Distinct Effects of TGF-{beta}1 on CD4+ and CD8+ T Cell Survival, Division, and IL-2 Production: A Role for T Cell Intrinsic Smad3 J. Immunol., February 15, 2005; 174(4): 2071 - 2083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mamura, W. Lee, T. J. Sullivan, A. Felici, A. L. Sowers, J. P. Allison, and J. J. Letterio CD28 disruption exacerbates inflammation in Tgf-{beta}1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-{beta}1 Blood, June 15, 2004; 103(12): 4594 - 4601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. V. Parekh, D. V. R. Prasad, P. P. Banerjee, B. N. Joshi, A. Kumar, and G. C. Mishra B Cells Activated by Lipopolysaccharide, But Not By Anti-Ig and Anti-CD40 Antibody, Induce Anergy in CD8+ T Cells: Role of TGF-{beta}1 J. Immunol., June 15, 2003; 170(12): 5897 - 5911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bommireddy, V. Saxena, I. Ormsby, M. Yin, G. P. Boivin, G. F. Babcock, R. R. Singh, and T. Doetschman TGF-{beta}1 Regulates Lymphocyte Homeostasis by Preventing Activation and Subsequent Apoptosis of Peripheral Lymphocytes J. Immunol., May 1, 2003; 170(9): 4612 - 4622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bommireddy, I. Ormsby, M. Yin, G. P. Boivin, G. F. Babcock, and T. Doetschman TGF{beta}1 Inhibits Ca2+-Calcineurin-Mediated Activation in Thymocytes J. Immunol., April 1, 2003; 170(7): 3645 - 3652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cheng and J. P. Grande Transforming Growth Factor-{beta} Signal Transduction and Progressive Renal Disease Experimental Biology and Medicine, December 1, 2002; 227(11): 943 - 956. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Mori, Y. Terui, M. Tanaka, H. Tomizuka, Y. Mishima, M. Ikeda, T. Kasahara, M. Uwai, M. Ueda, R. Inoue, et al. Antitumor Effect of {beta}2-Microglobulin in Leukemic Cell-bearing Mice via Apoptosis-inducing Activity: Activation of Caspase-3 and Nuclear Factor-{{kappa}}B Cancer Res., June 1, 2001; 61(11): 4414 - 4417. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
